CNTX - Context Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CNTX is currently covered by 3 analysts with an average price target of $7. This is a potential upside of $3.96 (1066.67%) from yesterday's end of day stock price of $0.6.

Context Therapeutics's activity chart (see below) currently has 20 price targets and 28 ratings on display. The stock rating distribution of CNTX is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for CNTX is $9, Lowest price target is $5, average price target is $7.

Most recent stock forecast was given by BIREN AMIN from PIPER SANDLER on 24-Mar-2026. First documented stock forecast 02-Feb-2022.

Best performing analysts who are covering CNTX - Context Therapeutics:

Emily Bodnar Jason Mccarthy Jason Kolbert Silvan Tuerkcan Biren Amin Joseph Catanzaro

Currently out of the existing stock ratings of CNTX, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 26-Jun-2025

$7

$5.61 (403.60%)

$4

3 months 23 days ago
(24-Mar-2026)

0/2 (0%)

$3.82 (120.13%)

Buy Since 16-Oct-2025

$9

$6.39 (244.83%)

$9

8 months 11 days ago
(06-Nov-2025)

0/2 (0%)

$7.93 (741.12%)

Buy Since 09-May-2024

$5

$3.61 (259.71%)

8 months 11 days ago
(06-Nov-2025)

0/10 (0%)

$3.93 (367.29%)

Buy Since 08-Jan-2025

$4

$2.61 (187.77%)

$4

1 years 3 months 23 days ago
(24-Mar-2025)

0/2 (0%)

$3.24 (426.32%)

Buy Since 16-May-2024

$4.5

$3.11 (223.74%)

$4.5

1 years 9 months 20 days ago
(27-Sep-2024)

0/4 (0%)

$2.64 (141.94%)

Show more analysts

Please expand the browser size to see the chart

What is CNTX (Context Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CNTX (Context Therapeutics) with a proven track record?

EMILY BODNAR

Which analyst has the current lower performing score on CNTX (Context Therapeutics) with a proven track record?

JOSEPH CATANZARO

Which analyst has the most public recommendations on CNTX (Context Therapeutics)?

Emily Bodnar has 17 price targets and 22 ratings on CNTX

Which analyst is the currently most bullish on CNTX (Context Therapeutics)?

Jason Kolbert with highest potential upside - $6.39

Which analyst is the currently most reserved on CNTX (Context Therapeutics)?

Jason Mccarthy with lowest potential downside - $2.61

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?